Cytomegalovirus retinitis in immunocompetent patients: Case reports and literature review

Ocular Immunology and Inflammation

Volumn 21, Issue 4, 2013, Pages 324-328

  Radwan, Alaa ^a,b   Metzinger, Jamie Lynne ^a,b   Hinkle, David M ^a,b   Foster, C Stephen ^a,b,c  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

^b Massachusetts Eye Research and Surgery Institute   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cytomegalovirus; Immunomodulatory therapy; Inflammation; Posterior uveitis; Retinitis

Indexed keywords

ACICLOVIR; BEVACIZUMAB; BIMATOPROST; CORTICOSTEROID; CYCLOSPORIN A; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYSPORINE; PREDNISONE; TIMOLOL; TRIAMCINOLONE; TRIMETHOPRIM; UNCLASSIFIED DRUG; VALGANCICLOVIR; VIRUS DNA;

ADULT; ANTIVIRAL THERAPY; AORTA VALVE REGURGITATION; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DIAGNOSTIC TEST; DISEASE SEVERITY; DNA DETERMINATION; EYE EXAMINATION; HUMAN; HYPERTENSION; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LOW VISION; MALE; MITRAL VALVE PROLAPSE; PATIENT SELECTION; POLYMERASE CHAIN REACTION; RETINA FLUORESCEIN ANGIOGRAPHY; SEROLOGY; TREATMENT OUTCOME; UVEITIS; VITRECTOMY;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 84879768819     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2013.786095     Document Type: Article

References (20)

1. Carlstrom G. Virologic studies on cytomegalic inclusion disease. Acta Paediatr Scand. 1965;54:17-23
2. Krech U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull World Health Organ. 1973;49:103-106
3. Lopez-Contreras J, Ris J, Domingo P, et al. Disseminated cytomegalovirus infection in an immunocompetent adult successfully treated with ganciclovir. Scand J Infect Dis. 1995;27:523-525
4. Glasgow BJ, Weisberger AK. A quantitative and cartographic study of retinal microvasculopathy in acquired immunodeficiency syndrome. Am J Ophthalmol. 1994; 118: 46-56
5. Miyamoto K, Hiroshiba N, Tsujikawa A, et al. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci. 1998;39:2190-2194
6. Saidel MA, Berreen J, Margolis TP. Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. Am J Ophthalmol. 2005;140: 1141-1143
7. Vertes D, Snyers B, De Potter P. Cytomegalovirus retinitis after low-dose intravitreous triamcinolone acetonide in an immunocompetent patient: A warning for the widespread use of intravitreous corticosteroids. Int Ophthalmol. 2010;30: 595-597
8. Delyfer MN, Rougier MB, Hubschman JP, et al. Cytomegalovirus retinitis following intravitreal injection of triamcinolone: Report of two cases. Acta Ophthalmol Scand. 2007;85:681-683
9. Sekiryu T, Iida T, Kaneko H, et al. Cytomegalovirus retinitis after intravitreal triamcinolone acetonide in an immunocompetent patient. Jpn J Ophthalmol. 2008;52: 414-416
10. Britt W. Manifestations of human cytomegalovirus infection: Proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol. 2008;325:417-470
11. Yoshinaga W, Mizushima Y, Abematsu N, et al. Cytomegalovirus retinitis in immunocompetent patients. Nihon Ganka Gakkai Zasshi. 2008;112:684-687
12. England AC, Miller SA, Maki DG. Ocular findings of acute cytomegalovirus infection in an immunologically competent adult. N Engl J Med. 1982;307:94-95
13. Chawla HB, Ford MJ, Munro JF, et al. Ocular involvement in cytomegalovirus infection in a previously healthy adult. BMJ. 1976;2:281-282
14. Stewart MW, Bolling JP, Mendez JC. Cytomegalovirus retinitis in an immunocompetent patient. Arch Ophthalmol. 2005;123:572-574
15. Cheng J, Ke Q, Jin Z, et al. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog.2009;5:e1000427
16. Atzmony L, Grosfeld A, Saar N, et al. Inherited and acquired predispositions for thrombosis in immunocompetent patients with cytomegalovirus-associated thrombosis. Eur J Intern Med. 2010;21:2-5.
17. Henderly DE, Freeman WR, Causey DM, Rao NA. Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology. 1987;94:425-434
18. Lowance D, Neumayer HH, Legendre CM, et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med. 1999;340:1462-1470
19. Marshall BC, Koch WC. Antivirals for cytomegalovirus infection in neonates and infants: Focus on pharmacinetics, formulations, dosing, and adverse events. Paediatr Drugs. 2009;11:309-321
20. Park YS, Byeon SH. Cytomegalovirus retinitis after intravitreous triamcinolone injection in a patient with central retinal vein occlusion. Korean J Ophthalmol. 2008;22: 143-144